The ‘Re-Pricer’ Reckoning: Makena, Daraprim And Acthar Under Pressure

 
• By Michael McCaughan
  
increase in the cost of medicine
Makena, Daraprim and Acthar have all had a turn in the spotlight as a poster-child for outrageous drug prices. • Source: shuttershock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access